General Public
You are here
The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL Network) is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent or treat, and/or improve the outcome of patients who have, or who are at risk for, Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Primary studies
Ancillary studies
-
PRIMROSE: Effect of randomization to neuromuscular blockade on physical functional impairment and recovery in ARDS
-
Provider perceptions of neuromuscular blockade in ARDS (PETE ROSE)
-
Re-Evaluation of Systemic Early Neuromuscular Blockade and TransThoracic Ultrasound Assessment of the Diaphragm (ROSETTA)
-
RED ROSE (Reconciling Expected vs Delivered Tidal Volumes in ROSE with Patient-ventilator Dyssynchrony)
-
ROSE-Transthoracic Ultrasound Assessment of the Diaphragm (ROSETTA)
News & Announcements
Dec 17, 2015
It is with the heaviest of hearts and deepest sorrow that the PETAL Network notes the passing of Arthur “Art” P. Wheeler on December 17th, 2015.